Latest Commercialization News

Page 226 of 496
Tryptamine Therapeutics has enrolled the first patient in its pioneering clinical trial testing TRP-8803, an IV-infused psilocin formulation, for Binge Eating Disorder. The study aims to evaluate safety and efficacy, potentially reshaping treatment options for millions.
Ada Torres
Ada Torres
14 Oct 2025
EMVision Medical Devices has received a $3 million government grant to fund a clinical study demonstrating its emu™ brain scanner's impact on accelerating stroke diagnosis in rural emergency departments.
Ada Torres
Ada Torres
14 Oct 2025
Elixir Energy has confirmed 23 meters of net gas pay across three Permian formations at its Diona-1 well in Queensland, setting the stage for flow testing and potential near-term gas production.
Maxwell Dee
Maxwell Dee
14 Oct 2025
ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.
Ada Torres
Ada Torres
14 Oct 2025
Catalyst Metals has received regulatory approval to build an exploration tunnel at its Four Eagles gold project in Victoria, marking a pivotal step toward underground access and resource expansion. The company is advancing its high-grade gold resource with a secured processing facility and plans for further drilling in FY26.
Maxwell Dee
Maxwell Dee
14 Oct 2025
Odyssey Gold Limited has reported encouraging results from a technical study supporting open pit mining at its Tuckanarra Gold Project and signed a key Memorandum of Understanding to process ore at Monument Mining’s nearby Burnakura plant.
Maxwell Dee
Maxwell Dee
14 Oct 2025
Patronus Resources reports a robust $70 million in cash and investments alongside 2.3 million ounces of gold equivalent resources, underpinning a multi-commodity growth strategy across Western Australia and the Northern Territory.
Maxwell Dee
Maxwell Dee
14 Oct 2025
Pacific Edge reports a 9% decline in Cxbladder test volumes amid Medicare coverage loss but gains momentum with new clinical validation and a CMS pricing boost.
Ada Torres
Ada Torres
14 Oct 2025
Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Latrobe Magnesium has locked in $10 million through a placement and entitlement offer to complete its demonstration plant and push towards commercial-scale magnesium production.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.
Ada Torres
Ada Torres
13 Oct 2025
INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.
Ada Torres
Ada Torres
13 Oct 2025